Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (651-660 of 737) with videos related to

Pageof 74
Sort By:
International Journal of Hematology|November 13, 2019
Novel DDX41 variants in Thai patients with myeloid neoplasmsChantana Polprasert, June Takeda, Pimjai Niparuck, et al.
Blood|August 11, 2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AAnna M Jankowska, Hideki Makishima, Ramon V Tiu, et al.
Nature Communications|September 9, 2018
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
The Journal of Experimental Medicine|February 25, 2017
A myeloid tumor suppressor role for <i>NOL3</i>Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, et al.
Blood|November 4, 2017
Gene expression and risk of leukemic transformation in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
Blood|August 24, 2012
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Ramon V Tiu, Rami Komrokji, et al.
Cancer Reports (Hoboken, N.J.)|November 28, 2023
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidineShinichi Ogawa, Tatsuhiro Sakamoto, Ryota Matsuoka, et al.
Research Square|July 16, 2024
Histopathology of the Tongue in a Hamster Model of COVID-19John M Coggins, Marina Hosotani Saito, Rebecca Cook, et al.
Blood Advances|July 20, 2019
Distinct clinical and biological implications of <i>CUX1</i> in myeloid neoplasmsMai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2020
Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of DasatinibDaisuke Takekoshi, Yuma Matsui, Takuya Akutsu, et al.
Pageof 74

Showing results (651-660 of 737) with videos related to

Sort By:
Pageof 74
International Journal of Hematology|November 13, 2019
Novel DDX41 variants in Thai patients with myeloid neoplasmsChantana Polprasert, June Takeda, Pimjai Niparuck, et al.
Blood|August 11, 2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AAnna M Jankowska, Hideki Makishima, Ramon V Tiu, et al.
Nature Communications|September 9, 2018
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
The Journal of Experimental Medicine|February 25, 2017
A myeloid tumor suppressor role for <i>NOL3</i>Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, et al.
Blood|November 4, 2017
Gene expression and risk of leukemic transformation in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
Blood|August 24, 2012
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Ramon V Tiu, Rami Komrokji, et al.
Cancer Reports (Hoboken, N.J.)|November 28, 2023
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidineShinichi Ogawa, Tatsuhiro Sakamoto, Ryota Matsuoka, et al.
Research Square|July 16, 2024
Histopathology of the Tongue in a Hamster Model of COVID-19John M Coggins, Marina Hosotani Saito, Rebecca Cook, et al.
Blood Advances|July 20, 2019
Distinct clinical and biological implications of <i>CUX1</i> in myeloid neoplasmsMai Aly, Zubaidah M Ramdzan, Yasunobu Nagata, et al.
Internal Medicine (Tokyo, Japan)|June 16, 2020
Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of DasatinibDaisuke Takekoshi, Yuma Matsui, Takuya Akutsu, et al.
Pageof 74